Component information
No US or EU label exists for this exact combination, so information is shown for each component.
Use: Metformin Hydrochloride Tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults and pediatric patients 10 years of age and older with type 2 diabetes mellitus. US FDA label
Kidney dosing: Metformin (single-agent)Show full dosing details
- eGFR ≥60
- Usual dosing. Assess kidney function before starting and periodically (label).
- eGFR 30–59
- eGFR 45–59: usual dose; consider dose reduction if at high risk of lactic acidosis. eGFR 30–44: label advises not to start; if continuing, reduce to a maximum of 1,000 mg/day (KDIGO 2022; ADA-KDIGO 2022). Recheck eGFR every 3 to 6 months.
- eGFR 15–29
- Contraindicated (label). Stop if eGFR falls below 30.
- eGFR <15 (not on dialysis)
- Contraindicated (label).
- Hemodialysis (intermittent)
- Contraindicated (eGFR <30 per label).
- Peritoneal dialysis
- Contraindicated (eGFR <30 per label).
- CRRT
- Not appropriate; contraindicated in severe kidney impairment (label).
- Dialyzable? Yes: dialyzable with clearance up to 170 mL/min under good hemodynamic conditions; hemodialysis may help remove drug in suspected overdose (label).
- Monitoring eGFR before starting and at least periodically; more often in older adults. Stop before or at the time of iodinated contrast in at-risk patients per label. Hold temporarily during acute illness with dehydration, sepsis, hypoxia or acute heart failure, during procedures with restricted food or fluid intake, and for acute kidney injury; restart when eating and kidney function is stable (label 5.1).
From the Metformin monograph (renalcarematters.com, reviewed).
Note: Fixed-dose combinations may not allow the dose changes advised for each component; check the strength and use the single agents if a component needs adjusting.
Dosing: Altered kidney function
No kidney-specific text is available from the US label for this generic yet. Check the Philippine package insert in the products table.
Kidney dosing for each component (single-agent) is shown under Component information.
Kidney-specific guidance from renalcarematters.com: in preparation.
Dosage forms
Philippines
- Film-coated tablet: 50 mg/500 mg
Registered products in the Philippines
1 product registered with the Food and Drug Administration (FDA) Philippines list Gemigliptin + Metformin as the generic name. Registration status changes; confirm a product's current status on the FDA portal before relying on it.
| Package insert | |||||||
|---|---|---|---|---|---|---|---|
Zemimet SRGemigliptin (as tartrate sesquihydrate) + Metformin hydrochloride | 50 mg/500 mg Film-Coated TabletAlu/PVC-PE-PVDC Blister Pack x 14's (Box of 28's) | RxVAT-exempt | LG Chem Ltd.Korea | Gx International Inc. | DR-XY49195 | Sep 10, 2029 |
Source: FDA Philippines product registration database. "Valid until" is the registration validity date listed by the FDA; a past date may mean a renewal is pending. Package insert links point to files published by the FDA.
Formulary and pricing (Philippines)
Check availability
Prices and stock vary by branch; renalcarematters.com does not sell medicines or receive payment from pharmacies.
References
- Food and Drug Administration Philippines. Verification portal (product registrations). https://verification.fda.gov.ph
This page shows official label and registry text only; no renalcarematters.com clinical summary has been approved for it yet.
Last updated: .